Learn

Learn

Explore our list of resources

Depending on your rare disease journey, Global Genes provides you with the resource and community to enhance your learning.

Patient Stories

Living and Advocating Through a Complex Medical Journey: Erythromelalgia, Visual Snow Syndrome, and Autoimmune Dysregulation

Hello, my name is Sierra Domb. Since childhood, I have experienced Erythromelalgia (EM) and Autoimmune Dysregulation (AD). […]

Living with a RARE Disease

Living with Brugada Syndrome

Brugada is insidious, especially for someone my age. It tends to “hide” in the ECG. Many times, it looks normal… but it isn’t. And with the myocarditis I had at the same time, it was even harder to get a correct diagnosis. The doctors didn’t know whether the findings were due to Brugada or to myocarditis. After my hospitalization, and after I suffered a fainting episode, it was finally decided that I should be implanted with a defibrillator (ICD). When it happened, I felt like life was given back to me.

Living with a RARE Disease

He Is Three. His Voice Isn’t Lost —It’s Waiting to Be Heard.

By the time a genetic diagnosis of a rare mutation in the PPP3CA gene finally arrived, critical months — even years — had slipped away. Milestones were missed while we waited for answers. Early concerns were minimized, and our pleas for help were too often brushed aside until delays became severe. That delay is not just a bureaucratic failure; it is lost opportunity — lost time for therapies that could have helped him build strength, communication, and independence.

Living with a RARE Disease

The Beginning of Our Lowe Syndrome Journey

By Caroline Tsai The sun blazes overhead without a cloud in sight. Only a high of 90 […]

Inclusion

Invincible Never Invisible: A Decade of InvisiYouth

I was competitive tennis player as a teen and was unfortunately injured in training, which resulted in dealing with an injury and neurovascular condition that changed the trajectory of my life. I was thrust into the world of living with a chronic illness, years of trying to find proper diagnoses and treatments, all while balancing life as a teen/young adult. During this entire young adult experience, my doctors would tell me “wait” till they could fix my health to live my life fully… I created InvisiYouth out of my love of philanthropy, and my newfound passion to giving a voice for the young adult population living with all chronic illnesses and disabilities for the non-medical aspects of their lives with health struggles.

Living with a RARE Disease

Beauty in Being Rare

Classical HCU is a condition in which my liver has a defective enzyme that is supposed to break down methionine. Instead, it builds up and turns into homocysteine, which is extremely toxic to your body. These elevated levels can result in blood clots, strokes, and other life-threatening complications. I follow an extremely restrictive low-protein diet—only about 10 grams of whole protein per day—alongside a methionine-free formula, the medication called betaine, and a cocktail of vitamins and supplements.

Latest News

Big News for RARE-X and Rare Disease Families: Citizen Health Partnership

Dear Global Genes Community, Today, I’m thrilled to share an exciting new chapter for RARE-X and for […]

Drug Development

Acting FDA commissioner pledges to prevent political interference in rare disease meeting

Global Genes was honored to be invited by the FDA to participate in a closed roundtable discussion […]

Drug Development

CURE SYNGAP1 announces $111,960 investment in RARE-X partnership to advance ProMMIS patient-reported outcome measure data collection – PR46

CURE SYNGAP1 is proud to announce a strategic investment of $111,960 in RARE-X to accelerate the collection of high-quality […]

Savara’s Early Access Program

Savara’s Early Access Program (EAP) for molgramostim inhalation solution (molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune […]

Publication Announcement — RARE-X: Advancing Rare Disease Research Through Patient-Driven Data

Global Genes is excited to announce “RARE-X: A patient-driven approach for collecting symptom and patient-reported outcome data […]

Accelerating Rare Disease Research Through Collaboration: Global Genes and Notre Dame Launch the Research Acceleration Program

Global Genes and University of Notre Dame have partnered to launch the Research Acceleration Program, a collaborative […]

Explore our list of resources

Featured

Gene-Based Diagnosis 101: How to Successfully Navigate the Diagnostic Journey

A Case for Whole Genome Sequencing

Advances in Rare Immunological Diseases

Developmental Delays After Factor V Leiden Pregnancy

Patient Stories

Living and Advocating Through a Complex Medical Journey: Erythromelalgia, Visual Snow Syndrome, and Autoimmune Dysregulation

Living with Brugada Syndrome

He Is Three. His Voice Isn’t Lost —It’s Waiting to Be Heard.

The Beginning of Our Lowe Syndrome Journey

Invincible Never Invisible: A Decade of InvisiYouth

Beauty in Being Rare

Latest News

Big News for RARE-X and Rare Disease Families: Citizen Health Partnership

Acting FDA commissioner pledges to prevent political interference in rare disease meeting

CURE SYNGAP1 announces $111,960 investment in RARE-X partnership to advance ProMMIS patient-reported outcome measure data collection – PR46

Savara’s Early Access Program

Publication Announcement — RARE-X: Advancing Rare Disease Research Through Patient-Driven Data

Accelerating Rare Disease Research Through Collaboration: Global Genes and Notre Dame Launch the Research Acceleration Program

Industry News

Experimental Therapy Halts Infant’s Severe Seizures, Dubai Hospital Reports

Pelthos to Merge with Castle Creek, adding DEB Gene Therapy Candidate

FDA Grants Accelerated Approval for Inovio’s RRP Immunotherapy

Setara Launches with $90 Million to Develop Drugs for Rare Diseases and Broader Uses

New Biotech Launches as Part of a Father’s Quest to Get Treatment for Son

Yearning for Normal

Anthropic Acquires Mithril Medicine to Test AI-Supported Model for Rare Disease Drug Development

FDA Issues Draft Guidance on Personalized Gene-Editing Treatments for Rare Diseases

Longeveron Heart Defect Study Missed Main Endpoint, but Analysis Found Fewer Serious Cardiac Events in Infants

Genetic Counseling

RARE Advocacy Exchange Session 7, Getting a Precise Genetic Diagnosis

Global Genes Guide to Genetic Diagnosis

Global Genes 2025 Quick Guide Series

Angelina Spreading Light, Love, and Inspiration on CASK Gene Awareness Day

Team Wally Inspires During Fragile X Awareness Month

From First Symptoms to Advocate for Transverse Myelitis

Research Readiness

Scientists Uncover New Autoimmune Disease Genes

Scientists Develop New Gene Editing Approach Capable of Gene-Sized Insertions

Tiny Worms May Unlock New Treatments for Rare Childhood Disorder

Gene Therapy Innovators Share 2026 Breakthrough Prize

Illumina Partners with D3b to Advance Genomic Research in Pediatric Rare Diseases

UC Berkeley Partners with BioMarin to Accelerate Rare Disease Research

Mental Health & Wellness

RARE Advocacy Exchange Session 8, Knowing Your Rare Rights

Global Genes Guide to Starting a Nonprofit Patient Advocacy Organization

RARE Advocacy Exchange Session 6 : Grieving a RARE Diagnosis

A Student’s Perspective: Lessons from the 2025 RARE Drug Development Symposium

Global Genes Guide to Securing a State Proclamation for Rare Disease Awareness

Global Genes Guide to Your Rare Rights

Global Genes Guide to Fundraising

Global Genes Guide to Comprehensive Fundraising Strategic Documents

RARE Advocacy Exchange Session 5 : Interacting with FDA: PFDD and Listening Sessions

RARE Daily

Vertex Reports Published Results for IgA Nephropathy Drug Ahead of FDA Decision

Alnylam’s Huntington’s Drug Lowers Disease-Linked Protein in Early Trial

Merck KGaA to Acquire Silence Therapeutics for $1.3 Billion

Building Better Rare Disease Data

Priovant Will Seek Expanded Approval of Lisraya After Positive Results in Inflammatory Eye Disease

FDA approves BioCryst’s Pellet Formulation of Orladeyo for HAE

Search the RARE List